Ab­cam founder urges in­vestors to vote against Dana­her's $5.7B buy­out, seeks to re­turn as CEO

Af­ter mak­ing clear his op­po­si­tion to Dana­her’s buy­out of Ab­cam, Jonathan Mil­ner — Ab­cam’s founder and for­mer CEO — is wag­ing a cam­paign to take back con­trol.

In an open let­ter, Mil­ner urged Ab­cam share­hold­ers to vote against the $5.7 bil­lion ac­qui­si­tion, which val­ues Ab­cam’s pro­tein re­search tools busi­ness at $24 per share. Blast­ing the lead­er­ship team’s “in­ad­e­quate gov­er­nance, lack­lus­tre in­vestor re­la­tions, de­fi­cient cost con­trols, and sub­par ex­e­cu­tion,” he al­so re­it­er­at­ed his call for oust­ing the cur­rent CEO, CFO and chair­man and spelled out plans to re­in­stall him­self as full-time CEO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER